SOLICITATION NOTICE
99 -- FY22 DAF ACT COVID-19 Commercial Solutions Opening (CSO)
- Notice Date
- 11/23/2021 8:25:27 AM
- Notice Type
- Combined Synopsis/Solicitation
- NAICS
- 54171
— Research and Development in the Physical, Engineering, and Life SciencesT
- Contracting Office
- FA8101 AFSC PZIOA TINKER AFB OK 73145-9125 USA
- ZIP Code
- 73145-9125
- Solicitation Number
- FA810122SC001
- Response Due
- 9/30/2022 2:00:00 PM
- Archive Date
- 09/30/2022
- Point of Contact
- April Davison, Phone: 937-210-9860, Anna Mroz, Phone: 405-734-4629
- E-Mail Address
-
cso.dafact.covid@afwerx.af.mil, cso.dafact.covid@afwerx.af.mil
(cso.dafact.covid@afwerx.af.mil, cso.dafact.covid@afwerx.af.mil)
- Description
- The Department of the Air Force (DAF) has been tasked to address mission needs in response to the national crisis caused by the Corona Virus Disease 2019 (COVID-19) pandemic. The Air Force Senior Acquisition Executive (SAE) established the Department of the Air Force Acquisition COVID-19 Task Force (DAF ACT) across the acquisition enterprise (i) to execute all requirements from the Office of the Under Secretary of Defense for Defense Assisted Acquisition Cell (DA2) and (ii) to collect and consolidate funding requests needed to recover programs from COVID-19 impacts. The DAF ACT contains four primary lines of effort (LOE�s) LOE�s: (1) Relief for external assistance requirements; (2) Resilience for Defense Industrial Base Efforts;�(3) Recovery for consolidating funding requests that minimize program impacts; and (4) Rapid for solicitation and execution of large-scale rapid small business contracts across all lines of effort. As the U.S. Government response to the COVID-19 pandemic has evolved, the DA2 mission has also evolved to include the replenishment of the Strategic National Stockpile (SNS) and expand and preserve the domestic manufacture of key medical personnel protective equipment (PPE) items, screening and diagnostics instruments and supplies, finished drugs and active pharmaceutical ingredients and the associated finishing and delivery capabilities. The Department of the Air Force Acquisition Task Force combined with the DA2, will lead rapid solicitation and execution of contracts in support of the DA2 mission. This CSO announcement anticipates soliciting solution briefs through separate and periodically published Areas of Interest (AOI) to meet Department of Health and Human Services (HHS) COVID-19 response priorities, with an emphasis on SNS goals that achieve (1) more coverage to ensure sufficient inventory of major PPE, equipment and drugs associated with COVID-like pandemics, (2) greater insight to forecast requirements, (3) use various inventory management strategies and improved visibility into supply and demand, and (4) enhance manufacturing capacity to reduce dependency on foreign sources of supply. The CSO is a streamlined acquisition process that seeks to reduce acquisition�timelines and acquire new, innovative solutions that companies can bring forth to�meet the stated AoIs.��All details of the process shall be�governed by this CSO unless otherwise noted or expanded upon in each AoI.�Complete CSO details are contained in the attached document ""FY22 DAF ACT COVID-19 Commercial Solutions Offering (CSO)"" below. Interested parties should continue to monitor this Notice for updated information�and publication of specific AoIs. UPDATED 02�NOV 2021: CSO FA8101-22-S-C001�is updated by amendment to�publish the following Areas of Interest (AoI): AoI-0001 DOMESTIC INDUSTRIAL BASE EXPANSION OF ACRYLONITRILE BUTADIENE RUBBER (NBR) for NITRILE MEDICAL GLOVES_Closes 23 November 2021 at 4:00pm CST. AoI-0002 DOMESTIC INDUSTRIAL BASE EXPANSION OF KEY CHEMICALS FOR ACRYLONITRILE_Closes 23 November 2021 at 4:00pm CST. AoI-0003 N95 RESPIRATOR INDUSTRIAL BASE CAPACITY PRESERVATION_Closes 23 November 2021 at 4:00pm CST. UPDATED 03�NOV 2021: CSO FA8101-22-S-C001�is updated by amendment to�publish the following Area�of Interest (AoI): AoI-0004 Domestic Industrial Base Expansion of Isolation and Surgical (L2/L3/L4) Disposable Gowns Manufacturing and Medical Grade Man-Made Fibers for Production UPDATED 08 NOV 2021:�CSO FA8101-22-S-C001�is updated by amendment to�publish updated Area�of Interest (AoI) which contain�a due date of�12 November 2021at 04:00 PM CST for AoI question submission. UPDATED 16 NOV 2021: CSO FA8101-22-S-C001 is updated by amendment�to publish the Questions�and Answers in response to the CSO and AoI's.� The CSO document has also been amended�to correct a typographical error.� The aforementioned amendments do not change the due dates outlined in any of the AoIs. UPDATED 17 NOV 2021: CSO FA8101-22-S-C001 is updated by amendment to publish�updated�AoI-0003 N95 RESPIRATOR INDUSTRIAL BASE CAPACITY PRESERVATION_REVISION�to specificy/update the threshold and objective for ramp-up period. The aforementioned amendment does not change the due dates outlined within the AoI. UPDATED 23�NOV 2021: CSO 8101-22-S-C001 is updated by amendment as follows: 1)�AoI's 0001-0004 have been updated to extend the solution brief�deadline(s) to 7 Dec 2021 and allow amendments to previously submitted solutions.� 2) AoI-0003 N95 RESPIRATOR INDUSTRIAL BASE CAPACITY PRESERVATION has been amended to request additional information.� 3)�The Questions and Answers document has also been updated to change to make correct a typographical error and interchange the questions and answers from AoI-0003 and AoI-0004. Note: Specific contract information/response address is located within each posted AoI.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/38ad7c273b3b4a14833994e200077e41/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN06184590-F 20211125/211123230116 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |